Sarepta Therapeutics, Inc.
Leadership moves, last update 3 months ago
Pharma biotech · Headquarters United States
Everything we hold on Sarepta Therapeutics, Inc., newest first. Every line links to the filing or report it came from.
- 2026-06-04Headcount Not Stated Leadership moves
Sarepta Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change
Sarepta Therapeutics has updated its equity incentive plan, affecting compensation for employees. The announcement does not disclose specific hiring plans.
- 2026-02-25Headcount Not Stated Leadership moves
Sarepta Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change
Sarepta Therapeutics seeks a new CEO in Cambridge, with Douglas Ingram retiring by end of 2026 or upon successor appointment.
- 2025-12-31Pay Change Pay and benefits
SAREPTA THERAPEUTICS, INC.: $7,840,666 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2024-12-31Pay Change Pay and benefits
SAREPTA THERAPEUTICS, INC.: $1,978,086 total compensation for the principal executive officer, fiscal year ended 2024-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2023-12-31Pay Change Pay and benefits
SAREPTA THERAPEUTICS, INC.: $1,661,338 total compensation for the principal executive officer, fiscal year ended 2023-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2022-12-31Pay Change Pay and benefits
SAREPTA THERAPEUTICS, INC.: $124,938,694 total compensation for the principal executive officer, fiscal year ended 2022-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
Sarepta Therapeutics, Inc.. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 20, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/sarepta-therapeutics/ Licensed CC BY 4.0; every record links to the document behind it.The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker